Emily Kim

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 3

Top Topics

Emergency Department

Top Venues

Communications medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Masakazu Nambo, Taeko Nishiwaki-Ohkawa, Akihiro Ito, Zachary T Ariki, Yuka Ito, Yuuki Kato, Muhammad Yar, Jacky C-H Yim, Emily Kim, Elizabeth Sharkey, Keiko Kano, Emi Mishiro-Sato, Kosuke Okimura, Michiyo Maruyama, Wataru Ota, Yuko Furukawa, Tomoya Nakayama, Misato Kobayashi, Fumihiko Horio, Ayato Sato, Cathleen M Crudden, Takashi Yoshimura
Synthesis and preclinical testing of a selective beta-subtype agonist of thyroid hormone receptor ZTA-261. Communications medicine 4 (1) (2024)
Masakazu Nambo, Taeko Nishiwaki-Ohkawa, Akihiro Ito, Zachary T Ariki, Yuka Ito, Yuuki Kato, Muhammad Yar, Jacky C-H Yim, Emily Kim, Elizabeth Sharkey, Keiko Kano, Emi Mishiro-Sato, Kosuke Okimura, Michiyo Maruyama, Wataru Ota, Yuko Furukawa, Tomoya Nakayama, Misato Kobayashi, Fumihiko Horio, Ayato Sato, Cathleen M Crudden, Takashi Yoshimura
Synthesis and preclinical testing of a selective beta-subtype agonist of thyroid hormone receptor ZTA-261. Communications medicine 4 (1) (2024)
Masakazu Nambo, Taeko Nishiwaki-Ohkawa, Akihiro Ito, Zachary T Ariki, Yuka Ito, Yuuki Kato, Muhammad Yar, Jacky C-H Yim, Emily Kim, Elizabeth Sharkey, Keiko Kano, Emi Mishiro-Sato, Kosuke Okimura, Michiyo Maruyama, Wataru Ota, Yuko Furukawa, Tomoya Nakayama, Misato Kobayashi, Fumihiko Horio, Ayato Sato, Cathleen M Crudden, Takashi Yoshimura
Synthesis and preclinical testing of a selective beta-subtype agonist of thyroid hormone receptor ZTA-261. Communications medicine 4 (1) (2024)